Compare SPIR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPIR | AVXL |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.1M | 397.6M |
| IPO Year | N/A | N/A |
| Metric | SPIR | AVXL |
|---|---|---|
| Price | $12.04 | $4.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $13.10 | ★ $22.00 |
| AVG Volume (30 Days) | 894.0K | ★ 1.6M |
| Earning Date | 12-17-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $77,387,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.07 | N/A |
| P/E Ratio | $15.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.60 | $2.86 |
| 52 Week High | $21.43 | $13.99 |
| Indicator | SPIR | AVXL |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 57.76 |
| Support Level | $12.16 | $4.67 |
| Resistance Level | $13.69 | $5.36 |
| Average True Range (ATR) | 1.08 | 0.29 |
| MACD | 0.12 | 0.04 |
| Stochastic Oscillator | 54.22 | 65.08 |
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.